Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells

Nature Cell Biology

Volumn 13, Issue 5, 2011, Pages 541-549

  Ohi, Yuki ^a   Qin, Han ^a   Hong, Chibo ^a   Blouin, Laure ^a   Polo, Jose M ^b,c   Guo, Tingxia ^a,d   Qi, Zhongxia ^d   Downey, Sara L ^a   Manos, Philip D ^c,e   Rossi, Derrick J ^c,e   Yu, Jingwei ^d   Hebrok, Matthias ^a,d   Hochedlinger, Konrad ^b,c   Costello, Joseph F ^a   Song, Jun S ^d   Ramalho Santos, Miguel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c Harvard University   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C9ORF64 GENE; CONTROLLED STUDY; DNA METHYLATION; ECTODERM; ENDODERM; EPIGENETICS; GENE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; MELANOCYTE; MESODERM; MOUSE; NEWBORN; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RNA TRANSPORT; SKIN FIBROBLAST; SOMATIC CELL; TRANSCRIPTIONAL MEMORY;

IPS;

EID: 85027958626     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb2239     Document Type: Article

References (44)

1. Yamanaka, S. A fresh look at iPS cells. Cell 137, 13-17 (2009).
2. Feng, Q. et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704-712 (2010).
3. Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107, 4335-4340 (2010).
4. Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123 (2009).
5. Ghosh, Z. et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5, e8975 (2010).
6. Marchetto, M. C. et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4, e7076 (2009).
7. Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249-257 (2010).
8. Newman, A. M. & Cooper, J.B. Lab-speci-c gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258-262 (2010).
9. Bock, C. et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
10. Deng, J. et al. Targeted bisul-te sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27, 353-360 (2009).
11. Doi, A. et al. Differential methylation of tissue-and cancer-speci-c CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and-broblasts. Nat. Genet. 41, 1350-1353 (2009).
12. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
13. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
14. Polo, J. M. et al. Cell type of origin in-uences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848-855 (2010).
15. Hockemeyer, D. et al. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3, 346-353 (2008).
16. Maherali, N. et al. A high-efciency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340-345 (2008).
17. Utikal, J., Maherali, N., Kulalert, W. & Hochedlinger, K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510 (2009).
18. Yang, Y. H., Xiao, Y. & Segal, M. R. Identifying differentially expressed genes from microarray experiments via statistic synthesis. Bioinformatics 21, 1084-1093 (2005). (Pubitemid 40467932)
19. Hemesath, T. J. et al. Microphthalmia, a critical factor in melanocyte development, de-nes a discrete transcription factor family. Genes Dev. 8, 2770-2780 (1994). (Pubitemid 24375425)
20. Odom, D. T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378-1381 (2004). (Pubitemid 38269432)
21. Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
22. Irizarry, R. A. et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18, 780-790 (2008). (Pubitemid 351645068)
23. Avery, K., Avery, S., Shepherd, J., Heath, P. R. & Moore, H. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. Stem. Cells Dev. 17, 1195-1205 (2008).
24. Baker, D. E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215 (2007). (Pubitemid 46227120)
25. Li, S. S. et al. Target identi-cation of microRNAs expressed highly in human embryonic stem cells. J. Cell Biochem. 106, 1020-1030 (2009).
26. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal-broblasts. Proc. Natl Acad. Sci. USA 105, 2883-2888 (2008). (Pubitemid 351723638)
27. Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 (2009).
28. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801 (2009).
29. Warren, L. et al. Highly efcient reprogramming to pluripotency and directed differentiation of human cells with synthetic modi-ed mRNA. Cell Stem Cell 7, 618-630 (2010).
30. Campain, A. & Yang, Y. H. Comparison study of microarray meta-analysis methods. BMC Bioinform. 11, 408-418 (2010).
31. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55 (2008). (Pubitemid 351931978)
32. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
33. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodi-ed-broblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007). (Pubitemid 47538112)
34. Chapman, E. J., Kelly, G. & Knowles, M. A. Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol. Cancer Res. 6, 1154-1168 (2008).
35. Jung, Y., Park, J., Bang, Y. J. & Kim, T. Y. Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers. Lab. Invest. 88, 153-160 (2008). (Pubitemid 351161273)
36. Kim, T. Y., Zhong, S., Fields, C. R., Kim, J. H. & Robertson, K. D. Epigenomic pro-ling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res. 66, 7490-7501 (2006). (Pubitemid 44289203)
37. Sweetser, D. A. et al. Delineation of the minimal commonly deleted segment and identi-cation of candidate tumour-suppressor genes in del(9q) acute myeloid leukemia. Genes Chromosomes Cancer 44, 279-291 (2005). (Pubitemid 41397097)
38. Cai, L. Y. et al. Identi-cation of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers. Life Sci. 80, 1458-1465 (2007).
39. Hirasawa, Y. et al. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma. Oncology 71, 77-85 (2006).
40. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008). (Pubitemid 351501814)
41. Dai, M. H. et al. Evolving gene/transcript de-nitions signi-cantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, E175 (2005).
42. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
43. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007). (Pubitemid 44906106)
44. Grunau, C., Clark, S. J. & Rosenthal, A. Bisul-te genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 29, E65 (2001).